|
SOX4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.69610000000575E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.400900E-04 |
| Normal-vs-Stage2 |
1.167780E-02 |
| Normal-vs-Stage3 |
3.270400E-02 |
| Normal-vs-Stage4 |
3.313400E-01 |
| Stage1-vs-Stage2 |
9.153800E-01 |
| Stage1-vs-Stage3 |
7.773600E-01 |
| Stage1-vs-Stage4 |
3.176400E-02 |
| Stage2-vs-Stage3 |
9.145800E-01 |
| Stage2-vs-Stage4 |
1.500820E-01 |
| Stage3-vs-Stage4 |
2.163600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77100999999569E-05 |
| Normal-vs-AfricanAmerican |
1.917850E-03 |
| Normal-vs-Asian |
6.389800E-01 |
| Caucasian-vs-AfricanAmerican |
1.323200E-01 |
| Caucasian-vs-Asian |
2.053000E-01 |
| AfricanAmerican-vs-Asian |
2.504800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.823600E-04 |
| Normal-vs-Female |
5.96509999999384E-05 |
| Male-vs-Female |
2.361400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.643760E-02 |
| Normal-vs-Extreme_Weight |
9.799700E-04 |
| Normal-vs-Obese |
1.836730E-04 |
| Normal-vs-Extreme_Obese |
1.665570E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.464800E-01 |
| Normal_Weight-vs-Obese |
2.129400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.094000E-01 |
| Extreme_Weight-vs-Obese |
4.542200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.796800E-01 |
| Obese-vs-Extreme_Obese |
9.146400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.038600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.00379999995659E-06 |
| Normal-vs-Age(61-80Yrs) |
4.972500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.232200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.108200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.402600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.295800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.216300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.771700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.393850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.07699999976718E-07 |
| Normal-VS-Type2 PRCC |
5.501200E-01 |
| Normal-VS-KIRP CIMP |
3.856500E-02 |
| Normal-VS-Unclassified PRCC |
5.138300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.76979994495719E-10 |
| Type1 PRCC-VS-KIRP CIMP |
3.524800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.103200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.454400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.763100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.969000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.748000E-02 |
| Normal-vs-N1 |
1.009540E-02 |
| Normal-vs-N2 |
7.662300E-02 |
| N0-vs-N1 |
1.138220E-01 |
| N0-vs-N2 |
6.728200E-01 |
| N1-vs-N2 |
9.070000E-02 |
|
|
